Ocaratuzumab
id:
ocaratuzumab-248-2491130
title:
Ocaratuzumab
text:
Ocaratuzumab is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes. Phase I/II trials in relapsed/refractory follicular lymphoma have been completed in the United States (US) and Japan, and a Phase I trial was conducted in US rheumatoid arthri
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ocaratuzumab
date created:
date modified:
2023-11-17T06:58:17Z
main entity:
{"identifier":"Q7075663","url":"https://www.wikidata.org/entity/Q7075663"}
image:
fields total:
13
integrity:
14